Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,962,501

« Back to Dashboard

Claims for Patent: 5,962,501

Title: Enantiomer of carbazole derivative as 5-HT1-like agonists
Abstract:A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate, or hydtrate thereof, processes for preparing said compounds and pharmaceutical compostions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.
Inventor(s): Borrett; Gary Thomas (Stansted, GB), Kitteringham; John (Hertford, GB), Porter; Roderick Alan (Ashwell, GB), Shipton; Mark Ralph (Hertfordshire, GB), Vimal; Mythily (Edmonton, GB), Young; Rodney Christopher (Oxford, GB)
Assignee: SmithKline Beecham, p.l.c. (Brentford Middlesex, GB)
Application Number:08/770,926
Patent Claims: 1. (+)-6-Carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole succinate monohydrate.

2. A pharmaceutical composition comprising the compound according to claim 1 and a physiologically acceptable carrier.

3. A method of treatment of a condition wherein a 5-HT.sub.1 -like agonist is indicated, which comprises administering to a subject in need thereof an effective amount of the compound according to claim 1.

4. The method of treatment according to claim 3, wherein the condition is migraine.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.